Stay updated on 24H Alteplase in Ischemic Stroke Clinical Trial
Sign up to get notified when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.

Latest updates to the 24H Alteplase in Ischemic Stroke Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed guidelines and findings related to intravenous thrombolysis for ischemic stroke, which are crucial for understanding treatment protocols. Additionally, a version revision has been noted.SummaryDifference36%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 5, 2025.SummaryDifference0.2%
- Check59 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new study locations and a revised timeline for the treatment of ischemic stroke with alteplase. Key details such as eligibility criteria and contraindications for the treatment have also been clarified.SummaryDifference58%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to 24H Alteplase in Ischemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.